What are the risks to patients of stem cell transplants?

Stem cell transplantation is a complex process. However, the transplant procedure itself is straightforward, similar in fact to a blood transfusion.

The donor stem cells are transfused through a central line (a catheter) which goes into a major vein in the chest.

The donor stem cells travel through the circulatory system and the stem cells can then start homing to the bone marrow and start dividing and replenishing the immune and blood system.

Chemotherapy and Infection

Once a stem cell transplant has taken place it can take several weeks or months for the donor cells to engraft. Engraftment means the stem cells have started to proliferate (reproduce themselves) within the recipient host.

Before stem cells can be transplanted a patient must undergo high dose chemotherapy. Following transfusion, the patient must be isolated for several weeks or months to avoid infection and to give the donated stem cells a chance to grow and proliferate.

While a patient is waiting for a stem cell transplant to engraft their immune system is severely compromised, because chemotherapy has essentially destroyed it. Therefore, infections before the donated stem cells successfully engraft can be serious and sometimes fatal – this is why patients are kept in isolation for several months, while their body and the donor stem cells grow a corrected, fully functional immune system.

Chemotherapy has significant side effects on the digestive system and sometimes on the body as a whole. Adults cannot withstand the levels of toxicity in chemotherapy that children invariably can and in elderly patients the risk is greater still.

Transplant Failure and GvHD

Failure to engraft, otherwise known as transplant rejection, is another risk. This means the donor recipient’s body has decided the donor stem cells are a threat, rejecting them.

In some cases, transplanted cells and the recipient’s cells can clash in the opposite way, causing what is called “graft versus host disease” (GvHD). This is where the donor cells attack the person who has received the transplant.

GvHD can happen within days of transplants – and up to two years later.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Cord blood hailed as disease cure

    It’s an endless search in the health field to find cures for diseases. What we’ve learned in recent decades is the cure could come from something we are all born with. The umbilical cord is considered

    WideCells Group PLC

    Stem Cells Potentially Repairing Joint Cartilage

    Researchers have identified and characterised unique cell populations that form the superficial zone of human joint cartilage for the first time, the zone has the most critical role in cushioning joints and is often partially or

    WideCells Group PLC

    Widecells: Protect your family’s future

    BabyCells The extraordinary way of looking after your family’s future… A crucial time for both you and your baby is at the time of birth, a time when we wouldn’t want you to miss out on

    WideCells Group PLC

    Why WideCells?

    What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new and better healthcare options. It’s our

    WideCells Group PLC

    WideCells Group PLC CellPlan Launch in Spain

    WideCells’ CEO, João Andrade, said, “We are delighted to launch CellPlan in Spain, one of the most established stem cell markets in Europe. Given the positive uptake and interest shown from new Stem Cell clients, with

    WideCells Group PLC

    Stem Cells is a Growing Business in More Ways Than One

    These days the medical and research literature abounds with stories about stem cells and what part they are playing in regenerative medicine, cures for cancer, and other treatments. Separating the hype from the reality, and the